VOLITIONRX LTD

VNRX · XNYS

CIK 93314fmd_0MTC270Z0KKGVDS647M94QJSDDManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard

Coverage: Jan 01, 2011 to Sep 30, 2026, 63 periods

Ratios computed from the standardized statements. Select a value to open its proof.